SynthesisThe journal of allergy and clinical immunology. In practice2022
The Role of Access and Cost-Effectiveness in Managing Asthma: A Systematic Review.
Synthesis in The journal of allergy and clinical immunology. In practice, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- A Digital Asthma Self-Management Program for Adults: A Randomized Clinical Trial.JAMA network open · 2025Trial
- Article
- The Global Patient Perspective on Uncontrolled Moderate-to-Severe Asthma: Reducing Delays in Diagnosis and Treatment.Advances in therapy · 2025Article
- The treatable traits of asthma in pregnancy: a clinical audit.ERJ open research · 2024Article
- Machine Learning Approaches to Predict Asthma Exacerbations: A Narrative Review.Advances in therapy · 2024Review
- Patient autonomy in self-managing their bronchial asthma exacerbation and its associated factors, 2024.Frontiers in allergy · 2024Article
- The relationship between neighborhood economic deprivation and asthma-associated emergency department visits in Maryland.Frontiers in allergy · 2024Article
- Asthma patients' perspectives on telehealth in disease management: A focus group study.Health care transitions · 2023Article
- The emerging role of digital health in the management of asthma.Therapeutic advances in chronic disease · 2023Review
- Home Monitoring of Asthma Exacerbations in Children and Adults With Use of an AI-Aided Stethoscope.Annals of family medicineObservational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundInconsistent and unequal access to medical care is an issue that predates the COVID19 pandemic, which only worsened the problem. Limited access to care from asthma specialists and other specialists treating comorbid diseases may adversely affect asthma.
objectiveThe purpose of this review is to identify health disparities associated with access to care for asthma, and cost-effectiveness of therapies and interventions addressing this health disparity.
methodsA narrative systematic review was undertaken using MeSH searches of English language articles published in CINAHL, Scopus, or PubMed.
resultsA total of 725 articles were identified. Barriers recognized from the literature included access to diagnostic spirometry, access to specialists, medication formulary restrictions, and issues leading to medical nonadherence. Telemedicine, school-based health care interventions, digital applications, and non-office-based digital spirometry could be used to address these gaps in access to asthma care while potentially being cost-effective.
conclusionWith the widespread adoption of telemedicine because of the pandemic, and adoption of other mobile services, we now have potential tools that can increase access to asthma care, which can help address this health care inequity. Evidence is limited, but favorable, that some of these tools may be cost-effective.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.